Literature DB >> 35353980

Proven Nasal and Pulmonary Aspergillosis in Patient with Severe Fever with Thrombocytopenia Syndrome.

Gil Myeong Seong1, Chang Lim Hyun2, Suk Won Chang3, Jeong Rae Yoo1.   

Abstract

Entities:  

Year:  2022        PMID: 35353980      PMCID: PMC9263345          DOI: 10.4046/trd.2022.0030

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


× No keyword cloud information.
A 72-year-old woman presented to the emergency department of our hospital with altered mental status (10 on the glass coma scale), without a medical history. On her first hospital visit, laboratory tests revealed the following: white blood cell count, 8,300/μL (4,000–10,000); platelet count, 43,000/μL (150,000–450,000); creatinine, 2.0 mg/dL (0.5–0.9); ferritin >1,675.5 ng/mL (4.6–204.0); and C-reactive protein, 12.6 mg/dL (0.0–0.3). The sequential organ failure assessment score was 10 and she was admitted to the intensive care unit. On the second day of admission, severe fever with thrombocytopenia syndrome (SFTS) virus was detected by real-time reverse transcription-polymerase chain reaction. Chest computed tomography (CT) scan, bronchoscopy, and serum aspergillosis antigen test were performed according to our early diagnosis protocol of SFTS-associated pulmonary aspergillosis (SAPA). CT scan images revealed a multifocal consolidative lesion with some cavitation in both lower lungs (Figure 1). When a bronchoscope was inserted through the left nose, necrotic tissue surrounded by a clot was observed on the nasal septum (Figure 2A). Bronchoscopy revealed pseudomembranous lesions with some ulceration on the left main and upper lobe bronchus (Figure 2B). Due to high probability of SAPA, intravenous voriconazole was initiated. In subsequent tests, the serum Aspergillus antigen level was 4.2 (negative <0.5), and the Aspergillus species was isolated from bronchoalveolar lavage fluid. On her seventh day in the hospital, tissue specimens from the left nose and the left bronchus confirmed invasive aspergillosis (Figure 2C, D). After the treatment with oral voriconazole for 2 months, her clinical course was greatly improved. This study was approved by the Jeju National University Hospital Institutional Review Board (2020-10-00).
Figure 1.

Chest computed tomography scan revealed multifocal patchy (arrowheads) (A) and peribronchial consolidation in both lungs. A small cavitary change was observed in the right lower lobe consolidation (arrow) (B).

Figure 2.

(A) An ulcerative mass surrounded by a blood clot was observed in the left nostril, accompanied by septal perforation. (B) Bronchoscopy revealed cream-colored thick pseudomembrane with mucosal ulceration on the left main and upper lobe bronchus. Microscopical findings of the specimen obtained from the nasal septum (C) and left upper lobe bronchus (D) show numerous fungal hyphae, morphologically consistent with aspergillosis invading the necrotic mucosa and submucosal area (C, Gomori methenamine silver stain, ×400; D, H&E stain, ×400).

The invasive fungal disease may accompany the early clinical course of SFTS [1,2], which is associated with poor prognosis [3,4]. An invasive nasal and pulmonary aspergillosis was diagnosed in this patient, which had not been reported previously worldwide. For Aspergillus tracheobronchitis cases without lung lesions [5], bronchoscopy should be considered. Also, protocolized approach for early diagnosis of SAPA is important.
  5 in total

1.  Invasive pulmonary aspergillosis is a frequent complication in patients with severe fever with thrombocytopenia syndrome: A retrospective study.

Authors:  Ying Xu; Mingran Shao; Ning Liu; Jian Tang; Qin Gu; Danjiang Dong
Journal:  Int J Infect Dis       Date:  2021-02-25       Impact factor: 3.623

2.  Invasive Pulmonary Aspergillosis in Patients With Severe Fever With Thrombocytopenia Syndrome.

Authors:  Seongman Bae; Hye Jeon Hwang; Mi Young Kim; Min Jae Kim; Yong Pil Chong; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

3.  Proven invasive pulmonary aspergillosis in the early clinical course of severe fever with thrombocytopenia syndrome: Importance of an early diagnosis.

Authors:  Gil Myeong Seong; Jeong Rae Yoo; Joong-Goo Kim; Chang Lim Hyun; Misun Kim; Hyun Joo Oh; Keun Hwa Lee
Journal:  J Microbiol Immunol Infect       Date:  2021-01-28       Impact factor: 4.399

4.  Early-Warning Immune Predictors for Invasive Pulmonary Aspergillosis in Severe Patients With Severe Fever With Thrombocytopenia Syndrome.

Authors:  Lifen Hu; Qinxiang Kong; Chengcheng Yue; Xihai Xu; Lingling Xia; Tingting Bian; Yanyan Liu; Hui Zhang; Xuejiao Ma; Huafa Yin; Qiulin Sun; Yufeng Gao; Ying Ye; Jiabin Li
Journal:  Front Immunol       Date:  2021-05-07       Impact factor: 7.561

Review 5.  Severe Fever with Thrombocytopenia Syndrome Complicated with Pseudomembranous Aspergillus Tracheobronchitis in a Patient without Apparent Risk Factors for Invasive Aspergillosis.

Authors:  Kento Sakaguchi; Yasutaka Koga; Takeshi Yagi; Takashi Nakahara; Masaki Todani; Motoki Fujita; Ryosuke Tsuruta
Journal:  Intern Med       Date:  2019-07-31       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.